Clinical trials in Leidschendam – page 119

1 919 clinical trials in Leidschendam, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in the NetherlandsKlinischOnderzoek.nl

Leidschendam at a glance

1 919

clinical trials

Research sites1

Quick filters

1 919 trials in Leidschendam

Open in trial search

Neuroblastoma

Not recruiting

Study on Bevacizumab with Temozolomide and Irinotecan for Children with Relapsed or Refractory Neuroblastoma

Registered drugNo placebo

Study on Bevacizumab with Temozolomide and Irinotecan for Children with Relapsed or Refractory Neuroblastoma

Registered drugNo placebo

The Netherlands

Participants:0–17 years
Substances:Bevacizumab
Sponsor:The University Of Birmingham

Contact Research Centre

Pulmonary hypertension+1

Not recruiting

Study on the Safety and Effectiveness of Apixaban, Edoxaban, and Phenprocoumon for Patients with Chronic Thromboembolic Pulmonary Hypertension Undergoing Balloon Pulmonary Angioplasty

Registered drugNo placebo

Study on the Safety and Effectiveness of Apixaban, Edoxaban, and Phenprocoumon for Patients with Chronic Thromboembolic Pulmonary Hypertension Undergoing Balloon Pulmonary Angioplasty

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Acenocoumarol
Sponsor:St. Antonius Ziekenhuis

Contact Research Centre

Mucopolysaccharidosis II

Not recruiting

Study on the Effectiveness and Safety of DNL310 vs Idursulfase for Children and Young Adults with Mucopolysaccharidosis Type II

Registered drugNo placebo

Study on the Effectiveness and Safety of DNL310 vs Idursulfase for Children and Young Adults with Mucopolysaccharidosis Type II

Registered drugNo placebo

The Netherlands

Participants:0–17 years · 18–64 years
Substances:Idursulfase
Sponsor:Denali Therapeutics Inc.

Contact Research Centre

Prostate cancer

Not recruiting

Study of drug interactions between enzalutamide, morphine and edoxaban in patients with prostate cancer

Registered drugNo placebo

Study of drug interactions between enzalutamide, morphine and edoxaban in patients with prostate cancer

Registered drugNo placebo

The Netherlands

Participants:65+ years
Substances:Edoxaban
Sponsor:Stichting Radboud University Medical Center

Contact Research Centre

Endometrial cancer stage I+1

Not recruiting

Study on Sentinel Lymph Node Mapping Using Gallium-68 Chloride and Tilmanocept in Patients with High-Risk Endometrial Cancer

Registered drugNo placebo

Study on Sentinel Lymph Node Mapping Using Gallium-68 Chloride and Tilmanocept in Patients with High-Risk Endometrial Cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Tilmanocept
Sponsor:Universitair Medisch Centrum Utrecht

Contact Research Centre

Colitis ulcerative

Not recruiting

Study on the Effects of Hyperbaric Oxygen Therapy for Patients with Moderate-to-Severe Ulcerative Colitis

Registered drugNo placebo

Study on the Effects of Hyperbaric Oxygen Therapy for Patients with Moderate-to-Severe Ulcerative Colitis

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Oxygen
Sponsor:Amsterdam UMC Stichting

Contact Research Centre

Prophylaxis of nausea and vomiting

Not recruiting

Study on the Effectiveness of Aprepitant and Fosaprepitant in Preventing Nausea and Vomiting in Children Undergoing Chemotherapy

Registered drug

Study on the Effectiveness of Aprepitant and Fosaprepitant in Preventing Nausea and Vomiting in Children Undergoing Chemotherapy

Registered drug

The Netherlands

Participants:0–17 years
Substances:Aprepitant
Sponsor:Prinses Maxima Centrum voor Kinderoncologie B.V.

Contact Research Centre

Diabetes mellitus+1

Not recruiting

Study on the Effectiveness of Oxygen Therapy for Patients with Diabetic Foot Ulcers

Registered drugNo placebo

Study on the Effectiveness of Oxygen Therapy for Patients with Diabetic Foot Ulcers

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Oxygen
Sponsor:Amsterdam UMC Stichting

Contact Research Centre

Adrenoleukodystrophy

Not recruiting

Study on the Safety and Effectiveness of SBT101 Gene Therapy for Adults with Adrenomyeloneuropathy

InvestigationalNo placebo

Study on the Safety and Effectiveness of SBT101 Gene Therapy for Adults with Adrenomyeloneuropathy

InvestigationalNo placebo

The Netherlands

Participants:18–64 years
Sponsor:Swanbio Therapeutics Limited

Contact Research Centre

Neoplasm malignant

Not recruiting

Study of Nivolumab and Entinostat for Children and Adolescents with High-Risk Refractory or Relapsed Malignant Disease

Registered drugNo placebo

Study of Nivolumab and Entinostat for Children and Adolescents with High-Risk Refractory or Relapsed Malignant Disease

Registered drugNo placebo

The Netherlands

Participants:0–17 years · 18–64 years
Substances:Entinostat
Sponsor:Universitaetsklinikum Heidelberg AöR

Contact Research Centre

Coronary artery disease

Not recruiting

Study on the Effects of Ziltivekimab for Reducing Inflammation in Patients with Coronary Artery Disease

InvestigationalNo placebo

Study on the Effects of Ziltivekimab for Reducing Inflammation in Patients with Coronary Artery Disease

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Ziltivekimab
Sponsor:Amsterdam UMC Stichting

Contact Research Centre

Polymyalgia rheumatica

Not recruiting

Study on Rituximab for Patients with Relapsing Polymyalgia Rheumatica to Reduce Steroid Use

Registered drugNo placebo

Study on Rituximab for Patients with Relapsing Polymyalgia Rheumatica to Reduce Steroid Use

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Rituximab
Sponsor:Sint Maartenskliniek

Contact Research Centre

Other cities in the Netherlands

The busiest research cities in the country

All 101 cities in the Netherlands

Clinical research in Leidschendam

What the registry says about research in the country

01 Oncology - Lung Cancer Research

Multiple clinical trials focusing on non-small cell lung cancer (NSCLC) treatment advancements, evaluating novel therapeutic approaches including immunotherapy combinations and targeted treatments.

Advanced NSCLC treatments
Immunotherapy combinations
KRAS G12C inhibitors

Studies compare various treatment options to improve patient outcomes and survival rates.

02 Breast Cancer Studies

Comprehensive research into breast cancer treatments, particularly focusing on hormone receptor-positive and HER2-positive subtypes, investigating targeted therapies and chemotherapy combinations.

Metastatic breast cancer
HER2-positive therapy
Triple-negative breast cancer

Trials examine innovative treatment strategies and personalized approaches.

03 Hematologic Malignancies

Studies focusing on lymphoma treatments, including both Hodgkin and non-Hodgkin variants, evaluating response-adapted therapies and novel drug combinations.

Advanced Hodgkin Lymphoma
Follicular Lymphoma
Treatment optimization

Research aims to improve treatment outcomes while minimizing toxicity.

04 Gastrointestinal Oncology

Investigations into colorectal cancer and related conditions, including innovative surgical approaches and treatment strategies for recurrent disease.

Rectal cancer treatments
Esophagogastric cancer
Surgical innovations

Focus on improving surgical outcomes and treatment effectiveness.

05 Brain Metastases Research

Studies examining treatment options for cerebral radiation necrosis and brain metastases, including innovative detection methods and therapeutic approaches.

Radiation necrosis treatment
Metastatic detection
Targeted therapies

Research aims to improve detection and treatment of brain metastases.

Back to the Netherlands All countries